FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to method for enhancement of expression of molecular chaperone by cell and/or enhancement of activity of molecular chaperone in cells by treatment of cells with effective amount of derivative of hydroxylamine of the formula (I) 
or (II) 
. Invention relates also to novel derivatives of hydroxylamine and pharmaceutical compositions based on thereof. Invention allows to regulate cellular processes effectively. EFFECT: improved preparing method, enhanced effectiveness of regulation. 145 cl, 29 dwg, 5 tbl, 100 ex (79 + 21)
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOUNDS FOR TREATMENT AND PROPHYLAXIS OF DISEASES ARISING AS RESULT OF DAMAGE OF VASCULAR ENDOTHELIAL CELLS | 1997 |
|
RU2195273C2 |
| APPLICATION OF HDAC INHIBITORS FOR TREATING MYELOMA | 2006 |
|
RU2420279C2 |
| HYDROXAMATE DERIVATIVES SUITABLE AS DEACETYLASE INHIBITORS | 2001 |
|
RU2302408C2 |
| AROMATIC COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATING AND ANTIPROLIFERATIVE AGENTS | 2003 |
|
RU2386625C2 |
| METHOD OF PREPARING 3-HALOGENALKYL-1H- PYRAZOLES | 1996 |
|
RU2169143C2 |
| NEW FIVE-MEMBER HETEROCYCLES, THEIR PREPARING, THEIR APPLYING AND PHARMACEUTICAL PREPARATIONS COMPRISING THEREOF | 1998 |
|
RU2240326C2 |
| INHIBITORS OF ANTIGEN PRESENTATION BY II CLASS MHC MOLECULES AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2333219C2 |
| PI-3 KINASE DOSAGE REGIME | 2013 |
|
RU2630975C2 |
| COMBINATIONS | 2020 |
|
RU2840819C1 |
| PHARMACEUTICAL COMBINATIONS CONTAINING PYRIDO[4,3-d]PYRIMIDINE DERIVATIVES AS HSP90 INHIBITOR AND HER2 INHIBITOR | 2009 |
|
RU2532375C2 |
